Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.41ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.41ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.41NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.75.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.75.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.75.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.75.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.20ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.20ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.20NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CR.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CR.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CR.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CR.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
DV.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
DV.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
DV.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
DV.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BT.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BT.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BT.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BT.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XMENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XMENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XMNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.1.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.1.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.70ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.70ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.70ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.70NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.63ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.63ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.63ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.63NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.8.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.8.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.8.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.8.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used